09:00
Opening Remarks from the Conference Chairs
Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, Roche
CONTENT BLOCK 1
INDUSTRY TRENDS AND INNOVATIONS
09:05
FIRESIDE EXPERT KICK-OFF
Industry Trends: Innovations in Clinical Trial Design and Execution
“What does it take to make the EU clinical trial landscape more competitive?”
• EU Policy
• Innovations in Design (AI/ML, Knowledge Management)
• Innovations in Execution (DHTs, Decentralized Trials, and Site Experience)
Isabela Niculae, Head, Clinical Innovation and Digital Solutions, Global Clinical Operations, UCB
Joachim Lövin, Decentralised Clinical Trial (DCT) Specialist, Novo Nordisk
Lorcan Walsh, Head, Digital Endpoint Capability Centre, Development, Novartis
Moderated by: Marco Rafael, Regulatory Science Policy Leader, Roche
09:30
CASE STUDY
Optimizing Drug Development with Actionable Data Insights:
Secondary Use of Data: Multimodal Data Assets
• Roche's Approach and Leadership in Data Re-use - ROI and Responsibility to Patients
• Development of Datamarts to Generate Insights for Study and CDP Design
Marta Carrasco, Biomedical Data Insights Development Leader, Roche
09:50
CASE STUDY
Patient Recruitment Enabled through EHRs
Nadir Ammour, Global Lead, Clinical Innovation & External Partnerships, Sanofi
10:10
AI-Driven Clinical Trials: Accelerating Patient-Centric Breakthroughs in Research and Efficiency
Alison Holland, Chief Customer Officer, Medable
CONTENT BLOCK 2
Accelerating Patient-Centric Trials
11:00
CASE STUDY
Navigating Operational Challenges of Multimodal DHT Trials
Speaker TBA
11:20
CASE STUDY
Scaling Clinical Innovation - The Novartis Operating Model for Sustainable Success
This session will explore how Novartis’s Clin Ops Innovation team is transforming clinical operations. Discover how their comprehensive operating model scales innovation through a structured framework, ensuring alignment with operational needs and challenges. Learn how they measure success with clear criteria, match specific innovations to operational requirements, and consistently assess the innovation landscape to identify new opportunities. This session will provide valuable insights into Novartis’s systematic approach to driving sustainable, value-driven innovation in clinical trials.
Scott Askin, Portfolio Innovation Director, Global Clinical Operations, Novartis
11:40
Bringing Clinical Trials Direct-to-Patient
Rachel Newsome, Product Manager, Cambridge Cognition
12:00
PANEL
Identifying Innovations & Technologies Accelerating Patient-Centric Trials
Lauren Sunshine, Director, Product Management, Digital Health, Bristol Myers Squibb
Bola Grace, Senior Director, Digital Health, Digital Biomarkers, GSK
Sam Hariry, Global Head, Clinical Innovation, Novartis Institutes for BioMedical Research (NIBR)
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust
Moderated by: Judit Magos, Clinical Operations Manager, Idorsia
CONTENT BLOCK 3
Enhancing Diversity in Clinical Trials
13:30
PANEL
Patient Perspectives & Cultural Considerations in Clinical Trials
This panel will bring together a group of patients to explore how their perspectives on cultural considerations in clinical trials.
Moderated by: Steve Bourke, Founder, PersonalPulse
13:50
CASE STUDY
End to End Inclusive Research
What can early development bring to late stage development?
Thierry Lave, R&D Academy and Faculty Lead, Roche
14:10
CASE STUDY
IHI READI
This session will explore the collaboration behind the IHI-funded project - IHI READI - aimed at fostering a more cohesive and integrated clinical studies ecosystem for underserved (US) and underrepresented (UR) communities.
Lea Proulx, Patient Voice Partner, Roche
14:30
CASE STUDY
Frailty Diversity in Oncology Trials
Sebastian Heinzmann, Global Medical Science Leader, Roche
CONTENT BLOCK 4
IDEAS INTO ACTION
15:15
CASE STUDY
Technology Fit for Purpose:
Understanding of Potential Issues to Decrease Patient Burden On Your Study
Stephan Cichos, Strategic Project Leader, Clinical Data Strategy & Operations, Bayer
15:35
CASE STUDY
How MindMed is Deploying AI to do Analysis of Patient Interviews Around the Primary Endpoint of All Clinical Studies
Dan Karlin, Chief Medical Officer, MindMed
15:55
CASE STUDY
MSD’s In-House Site Selection Application – Data-Driven Performance Ranking for Optimized Clinical Trials
Richard Bobek, Associate Director, Clinical Data Science, MSD
16:15
Patient Perspective: First Hand Experience with DCTs
Patient Speaker TBA
16:30
CLOSING PANEL
DHTs in Clinical Trials: Reality Check and Key Takeaways from Patient and Site Interactions
Meri Kay Scott, Associate Vice President, Digital Health R&D, Eli Lilly & Company
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust
Matteo Lai, Chief Executive Officer, Empatica
Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, Roche
17:00
APÉRO & NETWORKING RECEPTION!